Can a text message help young cancer survivors kick the vape habit?

NCT ID NCT05967585

Ongoing Knowledge-focused Sponsor: St. Jude Children's Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at e-cigarette use among 500 teenage and young adult cancer survivors and tests a text-message based program to help them quit. Researchers will also interview patients and healthcare providers to find the best ways to offer this support in oncology clinics. The goal is to understand vaping behaviors and develop practical tools for quitting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: text-message based vaping cessation program (This is Quitting)
What this could lead to: If successful, this could provide an effective, scalable way to help young cancer survivors quit vaping, improving their long-term health.
What could go wrong: This is an early implementation study, not a large efficacy trial. The program may not work well for all survivors, and results may not apply to other groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer central nervous system neoplasm Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VAPING VAPING CESSATION

Contacts and locations

Locations

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.